Purpose The systematic review aims to analyze and summarize the characteristics of living
systematic review (LSR) for coronavirus disease 2019 (COVID-19). Methods Six databases …

Clinicians rely on dependable guidelines for point-of-care decision-making, while decision
aids facilitate shared decision-making (SDM). However, both encounter challenges in …

For over two years, the global COVID-19 pandemic has persisted, and its continuation is
anticipated. The emergence and rapid spread of numerous new virus variations across …

Background Neutralizing antibodies cocktail (casirivimab and imdevimab) has received
emergency use authorization recommendation by Food and Drug Administration (FDA) and …

Background & Aims: Monoclonal antibodies cazirivimab and imdevimab are used as a
combination drug in the treatment of severe acute respiratory syndrome coronavirus-2 …

Zusammenfassung Hintergrund Klinische Leitlinien, die entscheidend für eine
evidenzbasierte Gesundheitsversorgung sind, sollten stets auf dem neuesten Stand …

The emergence of the SARS-CoV-2 Omicron variant capable of escaping neutralizing
antibodies emphasizes the need for prophylactic strategies to complement vaccination in …

Background As the global COVID-19 pandemic reaches its 2nd year, over 270 million cases
and 5.3 million deaths have occurred globally. Nearly, 3000 clinical trials have been …

Background: Intravenous immunoglobulin (IVIg) is a potential treatment option for COVID‐19
patients. Although an increasing number of studies have been published to evaluate the …

As of 6 January 2022, there have been over 298 million confirmed cases of COVID-19 (12).
The pandemic has thus far claimed approximately 5.5 million lives (12). Vaccination is …